Abstract
Activation of Wnt/β-catenin signaling in p53-negative cells through the COX-2/PGE2 pathway. A, Schematic drawing of Wnt/β-catenin reporter assays (TOPFlash) of co-cultured AKTPNull-bottom cells with AKTPR270H-top cells or AKTPNull-top cells. B, Luciferase activities of Wnt reporter assays (TOPFlash) of AKTPNull-bottom cells co-cultured with AKTPNull-top cells or AKTPR270H-top cells are shown as a bar graph (mean ± SD). Each dot represents an independent experiment. The P value is provided. C, RNA-seq data for Ptgs2 in three independent AKTFPR270H/+ and AKTFPR270H/LOH organoid lines. fragments per kilobase of exon per million reads mapped, the mean fold change, and P value are provided. D, Immunoblotting results for p53 and COX-2 in three independent AKTPNull and AKTPR270H lines. GAPDH was used as the internal control. E, Representative fluorescence immunocytochemistry images for p53 (green) and COX-2 (red) of AKTPNull (left) and AKTPR270H (right) organoids. F, Representative image of fluorescence IHC for p53 (green) and COX-2 (red) of AKTPR270H liver metastatic tumor. Insets in E and F show enlarged images. Bars in E and F, 100 μm. G, Representative images of fluorescence IHC for COX-2 (red) and F4/80 (macrophages, green) or αSMA (myofibroblasts, green). Merged images are shown (right). Bars, 50 μm. H, Luciferase activities of Wnt reporter assays (TOPFlash) of AKTPNull-bottom cells in co-cultured AKTPNull-top or AKTPR270H-top cells or control AKTPNull-bottom monoculture cells in the presence or absence of COX-2 inhibitor, celecoxib, are shown as a bar graph (mean ± SD). Each dot represents an independent experiment. The P value is indicated. ns, not significant. I and J, Luciferase activities of Wnt/β-catenin reporter assays in AKTPNull cells treated with PGE2 (I) or AKTPNull cells co-cultured with AKTPR270H treated with EP2/EP4 inhibitors (J) are shown as bar graphs (mean ± SD). Data from two independent AKTPNull lines (#1 and #2) are shown. Each dot indicates an independent experiment. P values are provided.